Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99Tc-MDP in Psoriatic Arthritis
NCT05000086Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2019
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of technetium-99m-methylene diphosphonate in psoriatic arthritis (PsA), sponsored by Peking Union Medical College Hospital. Started Jun 2019; status: completed.
02
Drugs
technetium-99m-methylene diphosphonate
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT05000086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05000086.